Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus

Paul J W H Kappelle; Josefin Ahnström; Bert D Dikkeschei; Rindert de Vries; Wim J Sluiter; Bruce H R Wolffenbuttel; Arie van Tol; Lars Bo Nielsen; Björn Dahlbäck; Robin P F Dullaart

doi:10.1016/j.atherosclerosis.2010.07.048

Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus

Paul J W H Kappelle, Josefin Ahnström, Bert D Dikkeschei, Rindert de Vries, Wim J Sluiter, Bruce H R Wolffenbuttel, Arie van Tol, Lars Bo Nielsen, Björn Dahlbäck, Robin P F Dullaart

Afdeling for Klinisk Biokemi DIA

15 Citationer (Scopus)

Abstract

Plasma apolipoprotein M (apoM) is potentially anti-atherogenic, and has been found to be associated positively with plasma total, LDL and HDL cholesterol in humans. ApoM may, therefore, be intricately related to cholesterol metabolism. Here, we determined whether plasma apoM is affected by statin or fibrate administration in patients with diabetes mellitus.

Originalsprog	Engelsk
Tidsskrift	Atherosclerosis
Vol/bind	213
Udgave nummer	1
Sider (fra-til)	247-50
Antal sider	4
ISSN	0021-9150
DOI	https://doi.org/10.1016/j.atherosclerosis.2010.07.048
Status	Udgivet - 1 nov. 2010

Adgang til dokumentet

10.1016/j.atherosclerosis.2010.07.048

Andre filer og links

Link to publication in Scopus

Citationsformater

Kappelle, P. J. W. H., Ahnström, J., Dikkeschei, B. D., de Vries, R., Sluiter, W. J., Wolffenbuttel, B. H. R., van Tol, A., Nielsen, L. B., Dahlbäck, B., & Dullaart, R. P. F. (2010). Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus. Atherosclerosis, 213(1), 247-50. https://doi.org/10.1016/j.atherosclerosis.2010.07.048

@article{ea90aed737924c0b97e4b267c7b75a7b,

title = "Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus",

abstract = "Plasma apolipoprotein M (apoM) is potentially anti-atherogenic, and has been found to be associated positively with plasma total, LDL and HDL cholesterol in humans. ApoM may, therefore, be intricately related to cholesterol metabolism. Here, we determined whether plasma apoM is affected by statin or fibrate administration in patients with diabetes mellitus.",

author = "Kappelle, \{Paul J W H\} and Josefin Ahnstr{\"o}m and Dikkeschei, \{Bert D\} and \{de Vries\}, Rindert and Sluiter, \{Wim J\} and Wolffenbuttel, \{Bruce H R\} and \{van Tol\}, Arie and Nielsen, \{Lars Bo\} and Bj{\"o}rn Dahlb{\"a}ck and Dullaart, \{Robin P F\}",

year = "2010",

month = nov,

day = "1",

doi = "10.1016/j.atherosclerosis.2010.07.048",

language = "English",

volume = "213",

pages = "247--50",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus

AU - Kappelle, Paul J W H

AU - Ahnström, Josefin

AU - Dikkeschei, Bert D

AU - de Vries, Rindert

AU - Sluiter, Wim J

AU - Wolffenbuttel, Bruce H R

AU - van Tol, Arie

AU - Nielsen, Lars Bo

AU - Dahlbäck, Björn

AU - Dullaart, Robin P F

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Plasma apolipoprotein M (apoM) is potentially anti-atherogenic, and has been found to be associated positively with plasma total, LDL and HDL cholesterol in humans. ApoM may, therefore, be intricately related to cholesterol metabolism. Here, we determined whether plasma apoM is affected by statin or fibrate administration in patients with diabetes mellitus.

AB - Plasma apolipoprotein M (apoM) is potentially anti-atherogenic, and has been found to be associated positively with plasma total, LDL and HDL cholesterol in humans. ApoM may, therefore, be intricately related to cholesterol metabolism. Here, we determined whether plasma apoM is affected by statin or fibrate administration in patients with diabetes mellitus.

UR - https://www.scopus.com/pages/publications/77958462840

U2 - 10.1016/j.atherosclerosis.2010.07.048

DO - 10.1016/j.atherosclerosis.2010.07.048

M3 - Journal article

C2 - 20828695

SN - 0021-9150

VL - 213

SP - 247

EP - 250

JO - Atherosclerosis

JF - Atherosclerosis

IS - 1

ER -

Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater